249 related articles for article (PubMed ID: 15962831)
1. Strategies for developing a successful Medicare part D formulary.
Stefanacci RG
Manag Care; 2005 May; 14(5 Suppl):3-10. PubMed ID: 15962831
[No Abstract] [Full Text] [Related]
2. What you need to know about Medicare Part D.
Consum Rep; 2006 Feb; 71(2):34-6. PubMed ID: 16509047
[No Abstract] [Full Text] [Related]
3. Perspectives. Options vs. limits: drug cost strategies reconsidered.
Cunningham R
Faulkner Grays Med Health; 1997 Sep; 51(38):suppl 4. PubMed ID: 10173171
[No Abstract] [Full Text] [Related]
4. Medicare pharmacy risk a bitter pill for the unprepared.
Public Sect Contract Rep; 1997 Jun; 3(6):81-6. PubMed ID: 10175081
[No Abstract] [Full Text] [Related]
5. The effect of the Medicare Part D benefit on medication management.
Pezalla E
Manag Care Interface; 2007 Jul; 20(7):13, 15. PubMed ID: 17849727
[No Abstract] [Full Text] [Related]
6. Medicare formulary model seen by many as too inclusive.
Carroll J
Manag Care; 2004 Nov; 13(11):10, 12. PubMed ID: 15595394
[No Abstract] [Full Text] [Related]
7. Implementing Medicare Part D could get ugly.
Manag Care; 2005 May; 14(5):53-4, 57-8. PubMed ID: 15962825
[No Abstract] [Full Text] [Related]
8. More drugs? Fewer drugs? Formulary wars rage on.
Med Health; 2004 Dec; 58(43):3-5. PubMed ID: 15612466
[No Abstract] [Full Text] [Related]
9. Medicare program: Medicare Advantage and prescription drug programs MIPPA drug formulary & protected classes policies. Interim final rule with comment period.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2009 Jan; 74(11):2881-8. PubMed ID: 19385109
[TBL] [Abstract][Full Text] [Related]
10. The formulary files. ARB costs run high in Medicare part D.
Manag Care; 2007 Aug; 16(8):48. PubMed ID: 17886540
[No Abstract] [Full Text] [Related]
11. Access to cancer drugs in Medicare Part D: formulary placement and beneficiary cost sharing in 2006.
Bowman J; Rousseau A; Silk D; Harrison C
Health Aff (Millwood); 2006; 25(5):1240-8. PubMed ID: 16966719
[TBL] [Abstract][Full Text] [Related]
12. Point/counterpoint. The HMO pharmacy benefit. In-house pharmacy administration: the benefits of integration.
Penna P
HMO; 1995; 36(4):56, 58-9. PubMed ID: 10166487
[No Abstract] [Full Text] [Related]
13. As drug costs rise, health plans shift the burden.
Capitation Manag Rep; 1997 Oct; 4(10):153-8. PubMed ID: 10175783
[No Abstract] [Full Text] [Related]
14. Surviving and thriving in the medicare part D market. Long-term partnerships can help health plans meet requirements.
Bridge L
AHIP Cover; 2006; 47(4):52, 54, 57. PubMed ID: 16894855
[TBL] [Abstract][Full Text] [Related]
15. Implementation of a pharmacy benefit to a managed Medicaid population.
Smith WW; Perry SC
Med Interface; 1995 Dec; 8(12):84-7, 97. PubMed ID: 10153524
[TBL] [Abstract][Full Text] [Related]
16. Do the Medicare math, then make quick decision.
Carroll J
Manag Care; 2004 Jan; 13(1):18-20. PubMed ID: 14763269
[No Abstract] [Full Text] [Related]
17. Point/counterpoint. The HMO pharmacy benefit. Contracted pharmacy services: the value of a carve-out PBM.
Reissman D
HMO; 1995; 36(4):57, 60-1. PubMed ID: 10166488
[No Abstract] [Full Text] [Related]
18. Medicare according to Bush: don't use that "P" word.
Scott JS
Healthc Financ Manage; 2003 Mar; 57(3):28-30. PubMed ID: 12747049
[No Abstract] [Full Text] [Related]
19. MMA formulary design requires health plans to control costs.
Sipkoff M
Manag Care; 2005 Jun; 14(6):18, 20. PubMed ID: 16044883
[No Abstract] [Full Text] [Related]
20. Data watch. Is this the way to manage pharmacy costs?
Bus Health; 1997 Sep; 15(9):94. PubMed ID: 10173238
[No Abstract] [Full Text] [Related]
[Next] [New Search]
